EGEGazette
Live
Houthis Accuse Saudi Arabia of 28 Airstrikes in 24 Hours; U.S. Intelligence Chief Visits CairoWashington Warns Citizens of Unexpected Escalation in Middle EastIran Says Strait of Hormuz Will Stay Closed Until US Meets Its ConditionsTrump faces dual setback as U.S. courts block voting and immigration restrictionsLawsuit Filed Against Trump and His Company Over Paid Early Access Service to His PostsTrump Renews Bid to Restrict Birthright Citizenship Through Curbing "Birth Tourism"Trump Cuts Camp David Vacation Short Amid Middle East Escalation WarningsTrump Cuts Short Vacation, Returns to White House as US Issues "Possible Escalation" Warning in Middle EastU.S. Military Announces Four Killed in Strike on Boat in Caribbean4 killed in US military strike on suspected drug-trafficking vessel in Caribbean SeaReporters From CNN, MS NOW and Politico Denied White House Access After Trump BanTrump Cuts Short Camp David Stay Amid Rising Middle East Tensions
businessReported

CNBC Analysts Highlight Biotech Stock Outperforming Broader Market

Josh Brown and Sean Russo point to a biotech name on their 'Best Stocks' list that they say is climbing despite wider market volatility.

· 1 min read · language: en
Article image
CNBC — Top News

A biotech stock included on a closely watched market list is bucking broader market trends and continuing to rise, according to CNBC contributors Josh Brown and Sean Russo.

In a segment discussing their "Best Stocks" list, Brown and Sean Russo examined the performance of the unnamed biotech company, noting that its share price has continued to push higher even as other segments of the market experienced volatility, according to CNBC.

The analysts did not specify the exact name of the biotech company in the publicly available excerpt of their discussion, nor did they detail the specific factors driving the stock's performance beyond noting it was "ignoring the market noise," per the report.

CNBC's "Best Stocks" list is a recurring feature on the network in which contributors identify equities they believe are showing notable strength or weakness relative to broader market conditions.

Further details on the stock's identity, its recent price movement, and the specific catalysts behind its performance were not included in the available excerpt of the segment.

Sources

EGazette summarizes reporting from multiple sources; follow the links for the originals.

Related articles

Comments

Sign in to join the conversation.

Forgot password?

No account?

Loading comments…